Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 4:30 PM View:  | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-24 | Option Exercise | 4,660 | -- | -- | 19% 24.07K to 28.73K | |
| 08-Apr-24 9:34 PM View: | Societal Cdmo, Inc. (SCTL) | 08-Apr-24 | Disposition | 73,620 | $1.10 | $80,982.00 | (25%) 291.05K to 217.43K | |
| 08-Apr-24 9:34 PM View: | Societal Cdmo, Inc. (SCTL) | 08-Apr-24 | Disposition (change in control) | 217,429 | $1.10 | $239,172.00 | (100%) 217.43K to 0 | |
| 16-Nov-23 4:15 PM View: | Mallinckrodt plc (MNKTQ) | 14-Nov-23 | Disposition | 96,660 | -- | -- | (100%) 96.66K to 0 | |
| 28-Aug-23 4:32 PM View: | Societal Cdmo, Inc. (SCTL) | 28-Aug-23 | Private Purchase | 62,500 | $0.40 | $25,000.00 | 27% 228.55K to 291.05K | |
| 18-Aug-23 9:21 PM View: | Mallinckrodt plc (MNKTQ) | 17-Aug-23 | Payment of Exercise | 15,976 | $0.69 | $11,071.40 | (14%) 112.64K to 96.66K | |
| 05-Jun-23 4:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jun-23 | Option Exercise | 4,507 | -- | -- | 23% 19.57K to 24.07K | |
| 19-May-23 4:55 PM View: | Societal Cdmo, Inc. (SCTL) | 17-May-23 | Grant | 73,620 | -- | -- | 48% 154.93K to 228.55K | |
| 22-Dec-22 5:47 PM View: | Mallinckrodt plc (MNKTQ) | 14-Dec-22 | Grant | 112,636 | -- | -- | 100% 0 to 112.64K | |
| 21-Jun-22 6:23 PM View: | Mallinckrodt plc (MNKTQ) | 16-Jun-22 | Disposition | 11,593 | -- | -- | (100%) 11.59K to 0 | |
| 06-Jun-22 5:33 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Jun-22 | Option Exercise | 3,356 | -- | -- | 21% 16.21K to 19.57K | |
| 20-May-22 5:36 PM View: | Societal Cdmo, Inc. (SCTL) | 18-May-22 | Grant | 87,500 | -- | -- | 130% 67.43K to 154.93K | |
| 22-Apr-21 5:58 PM View: | Societal Cdmo, Inc. (SCTL) | 20-Apr-21 | Grant | 26,923 | -- | -- | 66% 40.51K to 67.43K | |
| 07-Dec-20 4:13 PM View: | Mallinckrodt plc (MNKTQ) | 03-Dec-20 | Sale | 5,400 | $0.17 | $891.00 | (32%) 16.99K to 11.59K | |
| 08-Jun-20 5:46 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 06-Jun-20 | Option Exercise | 7,333 | -- | -- | 83% 8.88K to 16.21K | |
| 11-May-20 5:05 PM View: | Societal Cdmo, Inc. (SCTL) | 07-May-20 | Grant | 8,363 | -- | -- | 26% 32.14K to 40.51K | |
| 03-Apr-20 4:40 PM View: | Mallinckrodt plc (MNKTQ) | 01-Apr-20 | Payment of Exercise | 986 | $1.93 | $1,902.98 | (5%) 17.98K to 16.99K | |
| 04-Mar-20 4:27 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-20 | Option Exercise | 8,876 | -- | -- | 100% 0 to 8.88K | |
| 09-Dec-19 6:29 PM View: | Societal Cdmo, Inc. (SCTL) | 05-Dec-19 | Grant | 9,156 | -- | -- | 40% 22.99K to 32.14K | |
| 07-Jun-19 4:12 PM View: | Mallinckrodt plc (MNKTQ) | 07-Jun-19 | Market Purchase | 5,400 | $8.96 | $48,383.50 | 43% 12.58K to 17.98K | < 1% |
| 10-May-19 4:25 PM View: | Societal Cdmo, Inc. (SCTL) | 09-May-19 | Grant | 7,955 | -- | -- | 53% 15.03K to 22.99K | |
| 03-Apr-19 6:16 PM View: | Mallinckrodt plc (MNKTQ) | 01-Apr-19 | Grant | 12,579 | -- | -- | 100% 0 to 12.58K | |
| 23-Aug-18 4:50 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 21-Aug-18 | Sale | 11,698 | $23.65 | $276,658.00 | (12%) 94.68K to 82.99K | |
| 14-May-18 4:48 PM View: | Societal Cdmo, Inc. (SCTL) | 12-May-18 | Option Exercise | 8,849 | -- | -- | 143% 6.18K to 15.03K | |
| 08-May-18 4:08 PM View: | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 73,989 | -- | -- | (100%) 73.99K to 0 | |
| 08-May-18 5:28 PM View: | Societal Cdmo, Inc. (SCTL) | 04-May-18 | Grant | 6,183 | -- | -- | 100% 0 to 6.18K | |
| 08-May-18 7:22 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 04-May-18 | Grant | 94,684 | -- | -- | 100% 0 to 94.68K | |
| 05-Mar-18 12:46 PM View: | Impax Laboratories, LLC (IPXL) | 02-Mar-18 | Payment of Exercise | 3,069 | $19.50 | $59,845.50 | (3%) 97.75K to 94.68K | 6% |
| 27-Feb-18 12:19 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-18 | Payment of Exercise | 6,141 | $20.95 | $128,654.00 | (6%) 103.89K to 97.75K | 13% |
| 16-May-17 2:54 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-17 | Payment of Exercise | 454 | $16.80 | $7,627.20 | (< 1%) 104.35K to 103.89K | (9%) |
| 16-May-17 2:54 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-17 | Payment of Exercise | 705 | $17.65 | $12,443.20 | (< 1%) 105.05K to 104.35K | (4%) |
| 06-Mar-17 3:08 PM View: | Impax Laboratories, LLC (IPXL) | 02-Mar-17 | Grant | 23,272 | -- | -- | 28% 81.78K to 105.05K | |
| 27-Feb-17 8:23 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-17 | Payment of Exercise | 5,715 | $14.05 | $80,295.80 | (7%) 87.5K to 81.78K | (30%) |
| 27-Oct-16 12:05 PM View: | Impax Laboratories, LLC (IPXL) | 26-Oct-16 | Payment of Exercise | 1,209 | $21.35 | $25,812.20 | (1%) 88.7K to 87.5K | 14% |
| 16-May-16 3:42 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-16 | Payment of Exercise | 1,216 | $29.18 | $35,482.90 | (1%) 89.92K to 88.7K | 37% |
| 16-May-16 3:42 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-16 | Payment of Exercise | 1,889 | $29.18 | $55,121.00 | (2%) 91.81K to 89.92K | 37% |
| 14-Apr-16 1:01 PM View: | Impax Laboratories, LLC (IPXL) | 13-Apr-16 | Payment of Exercise | 1,035 | $35.35 | $36,587.20 | (1%) 92.84K to 91.81K | 48% |
| 01-Mar-16 4:13 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-16 | Grant | 26,113 | -- | -- | 38% 68.69K to 94.8K | |
| 01-Mar-16 4:13 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-16 | Payment of Exercise | 1,958 | $33.27 | $65,142.70 | (2%) 94.8K to 92.84K | 45% |
| 27-Oct-15 12:46 PM View: | Impax Laboratories, LLC (IPXL) | 26-Oct-15 | Payment of Exercise | 1,299 | $35.97 | $46,725.00 | (2%) 69.99K to 68.69K | 49% |
| 19-May-15 12:13 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-15 | Payment of Exercise | 1,391 | $44.44 | $61,816.00 | (2%) 71.38K to 69.99K | 59% |
| 19-May-15 12:09 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-15 | Payment of Exercise | 2,161 | $44.82 | $96,856.00 | (3%) 73.54K to 71.38K | 59% |
| 15-Apr-15 6:51 PM View: | Impax Laboratories, LLC (IPXL) | 13-Apr-15 | Payment of Exercise | 1,205 | $50.90 | $61,334.50 | (2%) 74.75K to 73.54K | 64% |
| 12-Mar-15 2:25 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-15 | Grant | 20,000 | -- | -- | 37% 54.75K to 74.75K | |
| 28-Oct-14 5:43 PM View: | Impax Laboratories, LLC (IPXL) | 26-Oct-14 | Payment of Exercise | 940 | $27.80 | $26,132.00 | (2%) 55.69K to 54.75K | 34% |
| 16-May-14 2:38 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-14 | Payment of Exercise | 1,400 | $25.56 | $35,784.00 | (2%) 57.09K to 55.69K | 28% |
| 16-May-14 2:38 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-14 | Grant | 23,000 | -- | -- | 67% 34.09K to 57.09K | |
| 14-Apr-14 2:00 PM View: | Impax Laboratories, LLC (IPXL) | 13-Apr-14 | Payment of Exercise | 1,216 | $24.55 | $29,852.80 | (3%) 35.3K to 34.09K | 25% |
| 28-Oct-13 8:30 PM View: | Impax Laboratories, LLC (IPXL) | 26-Oct-13 | Payment of Exercise | 939 | $20.47 | $19,221.30 | (3%) 36.24K to 35.3K | 11% |
| 16-May-13 5:24 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-13 | Grant | 14,800 | -- | -- | 69% 21.44K to 36.24K |